PAUL H KLINGENSTEIN Insider Trading
Get free email notifications about insider trading for PAUL H KLINGENSTEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PAUL H KLINGENSTEIN. PAUL H KLINGENSTEIN is a Director in EnteroMedics Inc ($ETRM) and a Director in Anacor Pharmaceuticals, Inc. ($ANAC) and a Director in Clovis Oncology, Inc. ($CLVS).
Address: 428 UNIVERSITY AVE C/O ACCEL PARTNERS PALO ALTO 94301 CA
Companies in which PAUL H KLINGENSTEIN is an Insider
Anacor Pharmaceuticals, Inc.
Trading Symbol: ANACIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL H KLINGENSTEIN: Director
Holdings: 1,751,936 shares
Latest Transaction: Dec 01 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Clovis Oncology, Inc.
Trading Symbol: CLVSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PAUL H KLINGENSTEIN: Director
Holdings: 59,327 shares
Current Value: $3,559,620
Latest Transaction: Jun 11 2021
$CLVS Market Capitalization: $2.45B
$CLVS Previous Close: $60.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ReShape Weightloss Inc.
Trading Symbol: RSLSIndustry: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
Position of PAUL H KLINGENSTEIN: Director
Holdings: 362,254 shares
Current Value: $2,658,944
Latest Transaction: Mar 27 2008
$RSLS Market Capitalization: $11.51M
$RSLS Previous Close: $7.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PAUL H KLINGENSTEIN
Sentiment: All, ANAC, CLVS, RSLS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 5.97 | 42,223 | 252,071 | 42,223 | |
Jun 05 2020 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
Jun 05 2020 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 6.48 | 40,138 | 260,094 | 40,138 | |
Jul 31 2019 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | M | 0.29 | 25,862 | 7,500 | 0 | |
Jul 31 2019 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Buy | M | 0.29 | 25,862 | 7,500 | 59,327 | 33.5 K to 59.3 K (+77.28 %) |
Jun 07 2019 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 | |
Jun 07 2019 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 14.66 | 28,882 | 423,410 | 28,882 |